Drug makers agonize over price cut of amlodipine generics

About 30 pharmaceutical firms, who are engaged in producing amlodipine maleate preparations, are attentively watching the government's final announcement on October 19, following the decision of the Health Insurance Review Agency to slash by 44 percent the current insurance price as part of efforts to drastically reduce the nation's medical insurance burden.

These drug manufacturers are worr...